Dublin, Jan. 30, 2017 -- Research and Markets has announced the addition of the "Long Chain Dicarboxylic Acid Market Analysis By Application, By Region And Segment Forecasts, 2013 - 2025" report to their offering.
The global long chain dicarboxylic acid market is expected to reach USD 300.3 million by 2025
Rising product use as LCDA applications such as nylon & other polyamide, powder coatings and lubricants will augment market growth over the next nine years.
The increasing use of long chain dicarboxylic acid as precursor in manufacturing of nylon & other polyamides, powder coatings, lubricants, adhesives, and corrosion inhibitors, applications will fuel the long chain dicarboxylic acid demand. Rising application scope of nylon & other polyamides in automotive and building construction is expected to propel long chain dicarboxylic acid growth over the forecast period.
Long chain dicarboxylic acid is employed as a key bio-based product for manufacturing in various applications. LCDA is an environmentally degradable product which makes its suitable for compliance with various regulatory norms laid by REACH and EPA in Europe and North America respectively.
High performance nylon & other polyamide used possess properties like high strength & stiffness, fatigue resistance, and broad temperature toleration. High performance nylon is widely used in infrastructure projects across various geographies of the world. The growth of above stated application segment is expected to fuel long chain dicarboxylic acid demand over the forecast period.
Further key findings from the report suggest:
- Long chain dicarboxylic acid market is expected to witness the growth at a CAGR of 7.0% from 2016 to 2025 due to its biodegradability, which also offers environmental advantage
- Pharmaceuticals as an application of LCDA will witness the fastest growth in terms of revenue at a CAGR of 8.7% from 2016 to 2024 owing to its superior bio-based properties
- North America market is expected to witness significant growth and was estimated at over USD 43 million in 2015 on account of rising infrastructure development and growing automotive industry
- Key participants include Cathay Industrial Biotech Ltd., Shandong Hilead Biotechnology Co., Ltd, Invista B.V, Zibo Guangtong Chemical Co., Ltd., and Evonik Industries AG
- Key companies in the market are focused on increasing their global presence through mergers & acquisitions and plant expansions.
- In June 2016, Cathay Industrial Biotech Ltd. announced capacity expansion for bio-based products that include long chain dibasic acids, bio-pentane diamine (DN5), and bio-polyamide (bio-PA)
- In October 2016, Invista opened a new 2,15,000-ton capacity hexamethylene diamine (HMD) plant and a 1,50,000-ton capacity polymer plant in China
Companies Mentioned
- Cathay Industrial Biotech Ltd.
- E. I. du Pont de Nemours and Company
- Evonik Industries AG
- Zibo Guangtong Chemical Co., Ltd.
- Shandong Hilead Biotechnology Co., Ltd.
- Invista B.V.
- Nantong Senos Biotechnology Co., Ltd.
- Henan Junheng Industrial Group Biotechnology Co., Ltd.
- Xiamen Aeco Chemical Industrial Co., Ltd.
- Capot Chemical Co., Ltd.
For more information about this report visit http://www.researchandmarkets.com/research/7tpdbz/long_chain
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Paints and Coatings , Lubricants and Greases


Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Anta Sports Expands Global Footprint With Strategic Puma Stake
Washington Post Publisher Will Lewis Steps Down After Layoffs
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
Samsung Electronics Shares Jump on HBM4 Mass Production Report
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning 



